圣诺生物：多位股东计划减持不超0.0120%股份

Core Viewpoint - The company, Saint Noble Biotechnology, announced that its Vice General Manager Ma Zhonggang and Director, Vice General Manager, and Financial Officer Wu Li plan to reduce their shareholdings due to personal financial needs [1] Group 1: Shareholding Reduction Details - Ma Zhonggang intends to reduce his holdings by no more than 18,816 shares, which represents up to 0.0120% of the company's total share capital [1] - Wu Li also plans to reduce his holdings by no more than 18,816 shares, equivalent to up to 0.0120% of the company's total share capital [1] - The reduction period is set to begin 15 trading days after the announcement, lasting from December 23, 2025, to March 22, 2026 [1] Group 2: Source and Compliance - The shares to be reduced are sourced from equity incentives obtained by the executives [1] - The implementation of the reduction plan will strictly adhere to relevant laws and regulations [1]